MetLife Denied Your Long-Term Disability Claim. The Supreme Court Already Ruled They Have a Conflict of Interest.

MetLife is a publicly traded company. When it pays disability benefits from its own funds, every claim paid is a direct cost to the company. The U.S. Supreme Court recognized this explicitly in MetLife v. Glenn (2008), finding that this structure creates an inherent conflict of interest in every MetLife ERISA denial.

Beyond the structural incentive, MetLife employs specialized internal medical reviewers, vocational experts, and investigators whose work is oriented toward finding grounds to limit or deny claims. Its policies frequently include 24-month limitations for mental health and neuromusculoskeletal conditions that it actively seeks to apply, and it uses the own-to-any occupation transition at 24 months as a systematic termination opportunity.

MetLife v. Glenn, 554 U.S. 105 (2008), is a landmark U.S. Supreme Court ruling in which MetLife was the defendant. The Court held that when an insurer both determines eligibility for ERISA disability benefits and pays those benefits from its own assets, a structural conflict of interest exists that federal courts must weigh when reviewing the denial.

This ruling does not mean MetLife's denial is automatically wrong. It means that the conflict is an active factor against MetLife in every abuse of discretion review — and the more evidence there is that the conflict actually influenced the decision (through financially motivated reviewers, selective record evaluation, or pressure to deny at the 24-month mark), the less deference the court gives to MetLife's conclusion. Building the administrative record to capture this evidence is a core part of Dorian Law's appeal strategy in MetLife cases.

The 24-month cliff refers to the convergence of two separate policy mechanisms at the two-year mark. First, most group LTD policies shift from the own occupation standard to the stricter any occupation standard at 24 months — significantly raising what you must prove to continue receiving benefits. Second, many MetLife policies separately cap benefits for disabilities caused or contributed to by mental or nervous conditions at 24 months.

MetLife typically intensifies its review in the months leading up to this mark, scheduling new IMEs, commissioning vocational assessments, and ordering additional medical reviews. Many claimants who received benefits without difficulty for the first two years are abruptly terminated at exactly this juncture. This is not coincidence — it reflects a systematic claims management approach designed around these policy thresholds.

Yes — and this is one of MetLife's most documented tactics. Many MetLife policies limit benefits for disabilities caused or contributed to by mental or nervous conditions to 24 months. When a claimant has a physical illness that has generated secondary depression or anxiety — which is extremely common — MetLife may attempt to characterize the disability as primarily mental health-driven in order to invoke the 24-month cap.

Courts have recognized this tactic and have found that MetLife must have a legitimate, evidence-based rationale for such a reclassification. Preventing it requires medical documentation that clearly establishes the physical condition as the independent, primary cause of disability, with the mental health component explicitly framed as secondary or reactive. Your treating physicians should address this specifically in any statements they provide to MetLife.

Under ERISA, you typically have 180 days from the date of MetLife's denial letter to file your administrative appeal. This deadline is stated in the denial letter. Missing it can permanently forfeit your right to appeal and to pursue your claim in federal court.

ERISA also imposes deadlines on MetLife: it must generally decide an appeal within 45 days (with one possible 45-day extension). MetLife has faced litigation alleging unreasonable delays beyond these regulatory timelines. In at least one documented case, MetLife's failure to meet its decision deadline created procedural advantages for the claimant and altered the litigation trajectory. Tracking MetLife's compliance with its own procedural obligations is part of a thorough appeal strategy.

After the 24-month own occupation period ends, MetLife must show you can perform some occupation for which you are reasonably suited. Its vocational specialists respond by identifying sedentary or light-duty positions — desk jobs, administrative roles — that they claim your residual functional capacity allows.

These assessments have a specific and documented vulnerability: MetLife's vocational experts rely heavily on the Dictionary of Occupational Titles (DOT), a federal publication last updated in 1991. Courts in the Ninth Circuit have criticized the DOT as an inadequate measure of which jobs actually exist in the modern economy and in what numbers — a problem that becomes acute when MetLife claims you can perform occupations that the modern labor market has substantially transformed or eliminated since 1991. An independent vocational expert who works from current labor market data and your actual functional limitations can expose the gap between what MetLife's DOT-based analysis claims and what the evidence actually supports.

Yes. MetLife hires private investigators to conduct physical and video surveillance, and monitors social media platforms for photographs, check-ins, or posts that appear inconsistent with claimed limitations. A single photograph at a social event or a video clip of brief activity can be presented in a termination letter as evidence of functional capacity.

Courts have rejected the use of isolated observation as definitive proof of absence of disability, particularly for fluctuating conditions. A claimant photographed at a wedding or seen walking to a car does not establish that they can work a full-time schedule. If your condition has good days and bad days, your attorney should address that variability explicitly in the appeal before MetLife deploys surveillance evidence as a termination basis.

Most MetLife policies give MetLife the contractual right to require an IME, and refusing to attend can jeopardize or forfeit your claim. You should attend. However, you should understand what an IME is: a one-time examination by a physician selected and paid by MetLife, often chosen based on a history of insurer-favorable opinions. The Ninth Circuit in Demer found that the financial relationship between MetLife and its consultants created a conflict of interest warranting skepticism.

Be truthful and consistent in describing your limitations. Document your experience during the exam — how long it lasted, what you were asked to do, what limitations you reported. Have your treating physician prepared to provide a detailed written rebuttal addressing any specific findings the IME report raises. Request a copy of the IME report, to which you are entitled under ERISA.

Under ERISA, MetLife is not required to give special deference to your treating physician, as the Supreme Court established in Black & Decker Disability Plan v. Nord (2003). It can assign more weight to its own internal reviewers' opinions. But the legal framework has teeth: courts must evaluate whether MetLife's reliance on those reviewers was reasonable, or whether it amounted to an abuse of discretion.

The Ninth Circuit addressed this directly in Demer v. IBM Corp. Short-Term Disability Plan, finding that the volume of income MetLife's reviewing consultants derived from insurer-paid reviews created a financial conflict of interest that warranted judicial skepticism of their conclusions — independent of the Glenn structural conflict. Where MetLife's paper reviewer contradicts a well-documented treating specialist opinion without examining the claimant, without the relevant specialty, or without engaging the specific clinical findings in the record, that gap becomes the basis for an abuse of discretion challenge. A targeted rebuttal from your treating physician that names and addresses each specific claim in the paper review is the tool that makes that challenge concrete.

MetLife most aggressively contests these claims, exploiting the absence of traditional objective markers to argue insufficient evidence. It may also attempt to apply self-reported symptom limitations or neuromusculoskeletal limitations to cap or deny benefits. These denials are contestable — and courts have said so directly.

A Delaware federal court found that MetLife committed an abuse of discretion by demanding objective test results for fibromyalgia and CFS where no such tests exist in standard medical practice, and by cherry-picking records that supported denial while ignoring substantial evidence of disability. Building a successful claim for these conditions requires detailed treating physician documentation of specific functional limitations — precisely how long you can sit, stand, concentrate, and maintain pace — supported by consistent clinical findings, specialist involvement, and where appropriate, neuropsychological or rheumatological testing that provides the maximum available objective data.